BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33350470)

  • 1. Epstein Barr virus infection and immune defense related to HLA-DR15: consequences for multiple sclerosis.
    Olsson T
    Eur J Immunol; 2021 Jan; 51(1):56-59. PubMed ID: 33350470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
    Zdimerova H; Murer A; Engelmann C; Raykova A; Deng Y; Gujer C; Rühl J; McHugh D; Caduff N; Naghavian R; Pezzino G; Capaul R; Zbinden A; Ferlazzo G; Lünemann JD; Martin R; Chatterjee B; Münz C
    Eur J Immunol; 2021 Jan; 51(1):64-75. PubMed ID: 32949466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
    De Jager PL; Simon KC; Munger KL; Rioux JD; Hafler DA; Ascherio A
    Neurology; 2008 Mar; 70(13 Pt 2):1113-8. PubMed ID: 18272866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.
    Ziaei A; Solomon O; Casper TC; Waltz M; Weinstock-Guttman B; Aaen G; Wheeler Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Waldman AT; Krupp L; James JA; Hart J; Barcellos LF; Waubant E
    Mult Scler; 2024 Mar; 30(3):308-315. PubMed ID: 38332747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
    Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
    PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune control of human γ-herpes infections.
    Münz C
    Semin Arthritis Rheum; 2024 Feb; 64S():152320. PubMed ID: 38007361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis.
    Xiao D; Ye X; Zhang N; Ou M; Guo C; Zhang B; Liu Y; Wang M; Yang G; Jing C
    Sci Rep; 2015 Dec; 5():18083. PubMed ID: 26656273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous human CD8 T cell and autoimmune encephalomyelitis-induced CD4/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive multiple sclerosis humanized immune system mice.
    Papazian I; Kourouvani M; Dagkonaki A; Gouzouasis V; Dimitrakopoulou L; Markoglou N; Badounas F; Tselios T; Anagnostouli M; Probert L
    Elife; 2024 Jun; 12():. PubMed ID: 38900149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.
    Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F
    J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DRB1*15:01 is a co-receptor for Epstein-Barr virus, linking genetic and environmental risk factors for multiple sclerosis.
    Menegatti J; Schub D; Schäfer M; Grässer FA; Ruprecht K
    Eur J Immunol; 2021 Sep; 51(9):2348-2350. PubMed ID: 34019695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Epstein-Barr virus infection with multiple sclerosis in India.
    Pandit L; Malli C; D'Cunha A; Shetty R; Singhal B
    J Neurol Sci; 2013 Feb; 325(1-2):86-9. PubMed ID: 23312038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
    Rubicz R; Yolken R; Drigalenko E; Carless MA; Dyer TD; Bauman L; Melton PE; Kent JW; Harley JB; Curran JE; Johnson MP; Cole SA; Almasy L; Moses EK; Dhurandhar NV; Kraig E; Blangero J; Leach CT; Göring HH
    PLoS Genet; 2013; 9(1):e1003147. PubMed ID: 23326239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.
    Kaushansky N; Eisenstein M; Boura-Halfon S; Hansen BE; Nielsen CH; Milo R; Zeilig G; Lassmann H; Altmann DM; Ben-Nun A
    J Biol Chem; 2015 Jun; 290(24):15260-78. PubMed ID: 25911099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Human Leucocyte Antigen Class II, with viral load and immune response to Epstein-Barr virus in adult and pediatric Systemic lupus erythematosus patients.
    Das P; Minz RW; Saikia B; Sharma A; Anand S; Singh H; Singh S
    Lupus; 2022 Aug; 31(9):1054-1066. PubMed ID: 35607991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.
    Pender MP; Csurhes PA; Pfluger CM; Burrows SR
    BMC Neurol; 2011 Aug; 11():95. PubMed ID: 21810280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA alleles modulate EBV viral load in multiple sclerosis.
    Agostini S; Mancuso R; Guerini FR; D'Alfonso S; Agliardi C; Hernis A; Zanzottera M; Barizzone N; Leone MA; Caputo D; Rovaris M; Clerici M
    J Transl Med; 2018 Mar; 16(1):80. PubMed ID: 29587799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.
    Tengvall K; Huang J; Hellström C; Kammer P; Biström M; Ayoglu B; Lima Bomfim I; Stridh P; Butt J; Brenner N; Michel A; Lundberg K; Padyukov L; Lundberg IE; Svenungsson E; Ernberg I; Olafsson S; Dilthey AT; Hillert J; Alfredsson L; Sundström P; Nilsson P; Waterboer T; Olsson T; Kockum I
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16955-16960. PubMed ID: 31375628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
    Waubant E; Mowry EM; Krupp L; Chitnis T; Yeh EA; Kuntz N; Ness J; Belman A; Milazzo M; Gorman M; Weinstock-Guttman B; Rodriguez M; James JA
    Mult Scler; 2013 Jun; 19(7):891-5. PubMed ID: 23232601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.